The plasticity of human Treg and Th17 cells and its role in autoimmunity.
暂无分享,去创建一个
[1] C. Baecher-Allan,et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. , 2009, Blood.
[2] C. Elson,et al. Late developmental plasticity in the T helper 17 lineage. , 2009, Immunity.
[3] D. Jarrossay,et al. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β , 2012, Nature.
[4] Hiromu Ito,et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model , 2007, The Journal of experimental medicine.
[5] S. Mazmanian,et al. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis , 2010, Proceedings of the National Academy of Sciences.
[6] M. Huber,et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype , 2008, Proceedings of the National Academy of Sciences.
[7] M. Pender,et al. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis. , 2008, Journal of autoimmunity.
[8] G. Eberl,et al. DC activated via dectin-1 convert Treg into IL-17 producers , 2008, European journal of immunology.
[9] F. Luft,et al. Mononuclear Phagocyte System Depletion Blocks Interstitial Tonicity-Responsive Enhancer Binding Protein/Vascular Endothelial Growth Factor C Expression and Induces Salt-Sensitive Hypertension in Rats , 2010, Hypertension.
[10] Y. Belkaid,et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. , 2009, Immunity.
[11] V. Kuchroo,et al. Induction and effector functions of TH17 cells , 2008, Nature.
[12] D. Jarrossay,et al. Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.
[13] R. Nurieva,et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. , 2009, Immunity.
[14] S. Mazmanian,et al. A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.
[15] Q. Wang,et al. Elevated Levels of CD4+CD25+FoxP3+ T Cells in Systemic Sclerosis Patients Contribute to the Secretion of IL-17 and Immunosuppression Dysfunction , 2013, PloS one.
[16] N. Tubridy,et al. CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis1 , 2009, The Journal of Immunology.
[17] W. Strober,et al. Cutting Edge: Regulatory T Cells Induce CD4+CD25−Foxp3− T Cells or Are Self-Induced to Become Th17 Cells in the Absence of Exogenous TGF-β , 2007, The Journal of Immunology.
[18] Thomas Korn,et al. IL-17 and Th17 Cells. , 2009, Annual review of immunology.
[19] D. Kasper,et al. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease , 2010, Mucosal Immunology.
[20] D. Munn,et al. Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. , 2009, Blood.
[21] Yong‐jun Liu,et al. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. , 2008, Immunity.
[22] E. Tolosa,et al. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. , 2009, Brain : a journal of neurology.
[23] C. Baecher-Allan,et al. Human regulatory T cells and their role in autoimmune disease , 2006, Immunological reviews.
[24] K. Berer,et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination , 2011, Nature.
[25] Yuka Kanno,et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. , 2009, Immunity.
[26] L. Cosmi,et al. Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells , 2012, European journal of immunology.
[27] B. Becher,et al. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation , 2011, Nature Immunology.
[28] C. Fathman,et al. Cd4+Cd25+ regulatory T cells and their therapeutic potential. , 2006, Annual review of medicine.
[29] T. Solstad,et al. CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells. , 2011, Blood.
[30] W. Paul,et al. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome , 2008, Nature.
[31] D. Hafler,et al. Regulatory T cells in the central nervous system , 2012, Immunological reviews.
[32] H. Weiner,et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor , 2008, Nature.
[33] S. Zheng,et al. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. , 2008, Trends in immunology.
[34] M. Veldhoen,et al. Fate mapping of interleukin 17-producing T cells in inflammatory responses , 2011, Nature Immunology.
[35] J. Bach. Regulatory lymphocytes: Regulatory T cells under scrutiny , 2003, Nature Reviews Immunology.
[36] Clare Baecher-Allan,et al. MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells1 , 2006, The Journal of Immunology.
[37] D. Green,et al. HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.
[38] Yuelei Shen,et al. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.
[39] D. Fox,et al. Th17 cells in human disease , 2008, Immunological reviews.
[40] I. Türbachova,et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells , 2007, European journal of immunology.
[41] K. Odunsi,et al. Interleukin 2-mediated Conversion of Ovarian Cancer-associated CD4+ Regulatory T Cells Into Proinflammatory Interleukin 17-producing Helper T Cells , 2009, Journal of immunotherapy.
[42] A. Regev,et al. Induction of pathogenic Th17 cells by inducible salt sensing kinase SGK1 , 2013, Nature.
[43] R. Geffers,et al. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. , 2006, Blood.
[44] Yoichiro Iwakura,et al. Review Functional Specialization of Interleukin-17 Family Members , 2022 .
[45] Richard Bonneau,et al. A Validated Regulatory Network for Th17 Cell Specification , 2012, Cell.
[46] K. Scharffetter-Kochanek,et al. Reduced CD18 Levels Drive Regulatory T Cell Conversion into Th17 Cells in the CD18hypo PL/J Mouse Model of Psoriasis , 2013, The Journal of Immunology.
[47] A. Abbas,et al. The life of regulatory T cells , 2013, Annals of the New York Academy of Sciences.
[48] A. Rudensky,et al. Foxp3 in control of the regulatory T cell lineage , 2007, Nature Immunology.
[49] R. Andreesen,et al. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. , 2006, Blood.
[50] Danila Valmori,et al. Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORγt , 2009, Proceedings of the National Academy of Sciences.
[51] J. Bluestone,et al. Control of TH17 cells occurs in the Small Intestine , 2011, Nature.
[52] S. Dasgupta,et al. Central Nervous System Demyelinating Disease Protection by the Human Commensal Bacteroides fragilis Depends on Polysaccharide A Expression , 2010, The Journal of Immunology.
[53] P. Krammer,et al. Prevalence of Newly Generated Naive Regulatory T Cells (Treg) Is Critical for Treg Suppressive Function and Determines Treg Dysfunction in Multiple Sclerosis1 , 2007, The Journal of Immunology.
[54] K. Alitalo,et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C–dependent buffering mechanism , 2009, Nature Medicine.
[55] Clare Baecher-Allan,et al. Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.
[56] D. Hafler,et al. FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.
[57] Ying Wang,et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.
[58] H. von Boehmer,et al. In Vivo Instruction of Suppressor Commitment in Naive T Cells , 2004, The Journal of experimental medicine.
[59] A. Rudensky,et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[60] Jay K Kolls,et al. The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation , 2022 .
[61] V. Boussiotis,et al. Runx1 and Runx3 Are Involved in the Generation and Function of Highly Suppressive IL-17-Producing T Regulatory Cells , 2012, PloS one.
[62] S. Mazmanian,et al. The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.
[63] D. Hoyt,et al. Hypertonic saline enhances cellular immune function. , 1994, Circulatory shock.
[64] Margaret A. Pericak-Vance,et al. The role of the CD58 locus in multiple sclerosis , 2009, Proceedings of the National Academy of Sciences.
[65] S. Mazmanian,et al. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota , 2010, Proceedings of the National Academy of Sciences.
[66] J. O’Shea,et al. Helper T‐cell identity and evolution of differential transcriptomes and epigenomes , 2013, Immunological reviews.
[67] A. Hamann,et al. Migration rules: functional properties of naive and effector/memory-like regulatory T cell subsets. , 2005, Current topics in microbiology and immunology.
[68] Sean M. Kearney,et al. Microbial Reprogramming Inhibits Western Diet-Associated Obesity , 2013, PloS one.
[69] G. Freeman,et al. CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.
[70] Kathleen M. Smith,et al. Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.
[71] J. Casanova,et al. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis , 2012, Current opinion in allergy and clinical immunology.
[72] Irma Joosten,et al. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. , 2008, Blood.
[73] M. Kleinewietfeld,et al. CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells. , 2009, Blood.
[74] Dan R. Littman,et al. Th17 and Regulatory T Cells in Mediating and Restraining Inflammation , 2010, Cell.
[75] L. Cosmi,et al. Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.
[76] G. Semenza,et al. Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 , 2011, Cell.
[77] G. Berry,et al. Induction of T helper type 1–like regulatory cells that express Foxp3 and protect against airway hyper-reactivity , 2004, Nature Immunology.
[78] D. Littman,et al. The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.
[79] Nathalie Arbour,et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.
[80] F. Sallusto,et al. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells , 2007, Nature Immunology.
[81] T. Nomura,et al. Regulatory T Cells and Immune Tolerance , 2008, Cell.
[82] C. Baecher-Allan,et al. Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease , 2011, Nature Medicine.
[83] A. Rudensky,et al. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 , 2005, Nature Immunology.
[84] J. Buer,et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins , 2008, Nature.
[85] Qizhi Tang,et al. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation , 2008, Nature Immunology.
[86] R. D. Hatton,et al. Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.
[87] S. Ziegler,et al. Isoform-Specific Inhibition of RORα-Mediated Transcriptional Activation by Human FOXP31 , 2008, The Journal of Immunology.
[88] David E. Anderson,et al. IL-21 and TGF-β are required for differentiation of human TH17 cells , 2008, Nature.
[89] A. Regev,et al. Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.
[90] M. Hattori,et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota , 2013, Nature.
[91] A. Hoischen,et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. , 2011, The New England journal of medicine.
[92] A. Rudensky,et al. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3 , 2007, Nature Immunology.
[93] S. Ho,et al. NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[94] Masahiro Yamamoto,et al. ATP drives lamina propria TH17 cell differentiation , 2008, Nature.
[95] S. Sakaguchi,et al. Development and maintenance of regulatory T cells. , 2013, Immunity.
[96] D. Harrison,et al. Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. , 2013, The Journal of clinical investigation.
[97] L. Cosmi,et al. Defining the human T helper 17 cell phenotype. , 2012, Trends in immunology.
[98] R. Kastelein,et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.
[99] Y. Wan,et al. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression , 2007, Nature.
[100] Chen Dong,et al. TH17 cells in development: an updated view of their molecular identity and genetic programming , 2008, Nature Reviews Immunology.
[101] P. Rossini,et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. , 2007, Blood.
[102] J. Zepp,et al. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. , 2011, Trends in immunology.
[103] M. Dallman,et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease , 2004, The Lancet.
[104] Sergio E. Baranzini,et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets , 2008, Nature.
[105] C. Baecher-Allan,et al. CD2 Costimulation Reveals Defective Activity by Human CD4+CD25hi Regulatory Cells in Patients with Multiple Sclerosis , 2011, The Journal of Immunology.
[106] J. Bluestone,et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo , 2009, Nature Immunology.
[107] J. O’Shea,et al. Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease. , 2013, The Journal of allergy and clinical immunology.
[108] Hilde Cheroutre,et al. Reciprocal TH17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid , 2007, Science.
[109] D. Hafler,et al. Increased Frequencies of Myelin Oligodendrocyte Glycoprotein/MHC Class II-Binding CD4 Cells in Patients with Multiple Sclerosis , 2011, The Journal of Immunology.
[110] M. S. Longhi,et al. The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies. , 2013, Journal of autoimmunity.
[111] Rodrigo Liberal,et al. Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis. , 2012, Gastroenterology.
[112] A. Hamann,et al. Homing to suppress: address codes for Treg migration. , 2005, Trends in immunology.
[113] D. Vignali,et al. How regulatory T cells work , 2008, Nature Reviews Immunology.
[114] Todd Davidson,et al. Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling , 2010, Nature.
[115] A. Bar-Or,et al. TLR2 Stimulation Drives Human Naive and Effector Regulatory T Cells into a Th17-Like Phenotype with Reduced Suppressive Function , 2011, The Journal of Immunology.
[116] M. Kleinewietfeld,et al. CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. , 2005, Blood.
[117] Chen Dong,et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. , 2008, Immunity.
[118] Y. Li,et al. Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis , 2011, Journal of Neuroimmunology.
[119] V. Kuchroo,et al. Th17: the third member of the effector T cell trilogy. , 2007, Current opinion in immunology.
[120] S. Rutz,et al. Regulation of epithelial immunity by IL-17 family cytokines. , 2012, Trends in immunology.
[121] V. Kuchroo,et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39 , 2013, Nature Immunology.
[122] P. Kivisäkk,et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis , 1999, Multiple sclerosis.
[123] Rapid In Vivo Conversion of Effector T Cells into Th2 Cells during Helminth Infection , 2012, The Journal of Immunology.
[124] Jonathan H. Esensten,et al. Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes , 2011, The Journal of Immunology.
[125] B. Engelhardt,et al. C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE , 2009, Nature Immunology.
[126] S. Zelenay,et al. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions , 2009, European journal of immunology.
[127] N. Yosef,et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells , 2013, Nature.
[128] P. Krammer,et al. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis , 2005, European journal of immunology.
[129] Chen Dong,et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. , 2008, Immunity.
[130] Jonathan S. Paw,et al. Response to self antigen imprints regulatory memory in tissues , 2011, Nature.
[131] Gary D. Stormo,et al. The AP-1 transcription factor Batf controls TH17 differentiation , 2009, Nature.
[132] T. Mcclanahan,et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.
[133] Dan R. Littman,et al. Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.
[134] Eva Tolosa,et al. Phenotypical Characterization of Human Th17 Cells Unambiguously Identified by Surface IL-17A Expression1 , 2009, The Journal of Immunology.
[135] M. Battaglia,et al. Erratum: Interleukin-10- secreting type 1 regulatory T cells in rodents and humans (Immunological Reviews (2006) 212, (28-50)) , 2006 .
[136] D. Littman,et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans , 2009, Proceedings of the National Academy of Sciences.
[137] J. Bluestone,et al. Plasticity of CD4(+) FoxP3(+) T cells. , 2009, Current opinion in immunology.
[138] M. Kleinewietfeld,et al. Hydrolysis of extracellular ATP by CD39+ Treg cells: context matters! , 2008 .
[139] R. Andreesen,et al. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation , 2009, European journal of immunology.
[140] L. Cosmi,et al. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. , 2008, International immunology.
[141] L. Harrington,et al. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. , 2006, Current opinion in immunology.
[142] A. Fischer,et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis , 2011, The Journal of experimental medicine.
[143] C. Elson,et al. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis. , 2011, Gastroenterology.
[144] P. van Erp,et al. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. , 2011, The Journal of investigative dermatology.
[145] F. Safavi,et al. The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF , 2011, Nature Immunology.
[146] A. Tsun,et al. Romance of the three kingdoms: RORgammat allies with HIF1alpha against FoxP3 in regulating T cell metabolism and differentiation , 2011, Protein & Cell.
[147] G. Schuler,et al. Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood , 2001, The Journal of experimental medicine.
[148] K. Honda,et al. Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.
[149] Katharina Fleischhauer,et al. Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans , 2006, Immunological reviews.
[150] S. Tangye,et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 , 2008, The Journal of experimental medicine.